Last Updated: January 6 2022

An Ayurvedic herb also classified as a phytopharmaceutical (H15; Europe) which appears to be quite anti-inflammatory, helpful against osteoarthritis, and may help cerebral edema. Boswellia serrata appears to have preliminary evidence for anti-inflammatory joint disorders.

Boswellia is most often used for


Boswellia Serrata is a gum resin extracted from a tree, which is sometimes burnt (the entire species of Boswellia is commonly known as Frankinsence) as an aromatic or otherwise administered as medicine. It has most usage for medicine in Ayurvedic medicine, some reading into Traditional Chinese Medicine, and its usage extends to the Middle East and other tropical regions.

Boswellia Serrata, via its active boswellic acids, appears to be a novel inhibitory of a pro-inflammatory enzyme called 5-Lipoxygenase and may possess other anti-inflammatory effects (such as nF-kB inhibition, which are not as novel). These anti-inflammatory effects have been investigated for their benefits in osteoarthritis (OA), and it appears that oral Boswellia supplements can suppress pain and immobility associated with OA quite significantly with the effects taking as little as a week to occur. The studies are well conducted, but funded by the producers of the tested supplements. There are limited non-funded interventions with Boswellic for this claim, but they seem to agree with the battery of funded study in effect size.

Remarkably, Boswellia appears to be quite anti-cancer that appears to be more anti-proliferative rather than apoptotic (the latter meaning to induce regulated cell death) since it is a potent inhibitor of angiogenesis and cell invasiveness. There are not a large battery of studies on these claims, but preliminary mouse and rat evidence where the rodents are injected with tumors suggest that Boswellia can potently suppress tumor growth (Pancreatic, Colorectal) and in some cases actually outright prevent tumor growth (Prostatic, Glioma). Boswellia appears to be a very promising anti-cancer herb due to the potency it exhibits in animals, with one study noting this after oral administration (100mg/kg of the main boswellic acid in animals). The potency has been replicated in other cancer cell lines in vitro (including breast, cervical, myeloma and leukemia) but these cancers do not yet have animal interventions yet.

Boswellia appears to be fairly nontoxic, has a history of usage as a phytopharmaceutical for brain edema associated with radiotherapy (a cancer treatment), and the general anti-inflammatory and anti-cancer effects make it a fairly interesting herb relative to others that have subpar evidence.

What else is Boswellia known as?
Note that Boswellia is also known as:
  • Indian Frankincense
  • Salai
  • Salai Guggul
  • Gajabhakshya
  • Boswellia Serrata
Boswellia should not be confused with:
Dosage information

If using boswellia serrata resin itself, doses can increase up to 1,800 mg taken thrice a day (5,400 mg daily), but are usually in the range of 800-1,200 mg taken thrice a day to total a daily dose of 2,400-3,600 mg. Within this range benefits appear to be dose-dependent.

Brand name products of boswellia serrata (ex. 5-LoxinTM, AflapinTM, AprèsFLEXTM) tend to have higher concentrations of AKBA, and are usually once daily doses of 100-250 mg taken with the first meal of the day.

For all forms of boswellia serrata, start at the lower end of the dosage range for 2-3 months and afterwards increase the dose. If greater benefits are not seen with the higher dose (ie. the benefits are similar to the lower dose) then continue supplementation with the lower dose.

Examine Database
1.^Tawab MA, Kaunzinger A, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz MDevelopment of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasmaJ Chromatogr B Biomed Sci Appl.(2001 Sep 25)
2.^Woolley CL, Suhail MM, Smith BL, Boren KE, Taylor LC, Schreuder MF, Chai JK, Casabianca H, Haq S, Lin HK, Al-Shahri AA, Al-Hatmi S, Young DGChemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometryJ Chromatogr A.(2012 Oct 26)
5.^Devi PR, Adilaxmamma K, Rao GS, Srilatha Ch, Raj MASafety Evaluation of Alcoholic Extract of Boswellia ovalifoliolata Stem-bark in RatsToxicol Int.(2012 May)
7.^Gerbeth K, Meins J, Kirste S, Momm F, Schubert-Zsilavecz M, Abdel-Tawab MDetermination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometryJ Pharm Biomed Anal.(2011 Dec 15)
8.^Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, Kashman Y, Huang SM, Lee H, Shohami E, Mackie K, Caterina MJ, Walker JM, Fride E, Mechoulam RIncensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brainFASEB J.(2008 Aug)
10.^Wang C, Xia L, Song Z, Li Q, Wang C, Zeng L, Liu ZDetermination of five boswellic acids in Boswellia serrataZhongguo Zhong Yao Za Zhi.(2011 May)
12.^Moussaieff A, Gross M, Nesher E, Tikhonov T, Yadid G, Pinhasov AIncensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animalsJ Psychopharmacol.(2012 Dec)
14.^Bhushan S, Kumar A, Malik F, Andotra SS, Sethi VK, Kaur IP, Taneja SC, Qazi GN, Singh JA triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cellsApoptosis.(2007 Oct)
19.^Song Z, Xia L, Wei Z, Cao Y, Zhang L, Liu ZDetermination of alpha-pinene and octyl acetate contents in Boswellia serrataZhongguo Zhong Yao Za Zhi.(2012 May)
20.^Khajuria A, Gupta A, Suden P, Singh S, Malik F, Singh J, Gupta BD, Suri KA, Srinivas VK, Ella K, Qazi GNImmunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrataPhytother Res.(2008 Mar)
23.^Sengupta K, Kolla JN, Krishnaraju AV, Yalamanchili N, Rao CV, Golakoti T, Raychaudhuri S, Raychaudhuri SPCellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extractMol Cell Biochem.(2011 Aug)
25.^Kumar A, Takada Y, Boriek AM, Aggarwal BBNuclear factor-kappaB: its role in health and diseaseJ Mol Med (Berl).(2004 Jul)
26.^Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DBNF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinaseNature.(1999 Sep 2)
27.^Ghosh S, Karin MMissing pieces in the NF-kappaB puzzleCell.(2002 Apr)
28.^Nakayama T, Sawada TInvolvement of microtubule integrity in memory impairment caused by colchicinePharmacol Biochem Behav.(2002 Jan-Feb)
31.^Avila J, Lucas JJ, Perez M, Hernandez FRole of tau protein in both physiological and pathological conditionsPhysiol Rev.(2004 Apr)
32.^Karima O, Riazi G, Khodadadi S, Yousefi R, Mahnam K, Mokhtari F, Cheraghi T, Hoveizi E, Moosavi-Movahedi AAAn in vitro study of the role of β-boswellic acid in the microtubule assembly dynamicsFEBS Lett.(2012 Nov 30)
34.^Krüger P, Kanzer J, Hummel J, Fricker G, Schubert-Zsilavecz M, Abdel-Tawab MPermeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2Eur J Pharm Sci.(2009 Feb 15)
36.^Gerbeth K, Hüsch J, Fricker G, Werz O, Schubert-Zsilavecz M, Abdel-Tawab MIn vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resinsFitoterapia.(2012 Oct 24)
37.^Hüsch J, Bohnet J, Fricker G, Skarke C, Artaria C, Appendino G, Schubert-Zsilavecz M, Abdel-Tawab MEnhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extractFitoterapia.(2012 Oct 23)
38.^Hüsch J, Gerbeth K, Fricker G, Setzer C, Zirkel J, Rebmann H, Schubert-Zsilavecz M, Abdel-Tawab MEffect of Phospholipid-Based Formulations of Boswellia serrata Extract on the Solubility, Permeability, and Absorption of the Individual Boswellic Acid Constituents PresentJ Nat Prod.(2012 Oct 26)
40.^Reising K, Meins J, Bastian B, Eckert G, Mueller WE, Schubert-Zsilavecz M, Abdel-Tawab MDetermination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometryAnal Chem.(2005 Oct 15)
41.^Tausch L, Henkel A, Siemoneit U, Poeckel D, Kather N, Franke L, Hofmann B, Schneider G, Angioni C, Geisslinger G, Skarke C, Holtmeier W, Beckhaus T, Karas M, Jauch J, Werz OIdentification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincenseJ Immunol.(2009 Sep 1)
44.^Siemoneit U, Pergola C, Jazzar B, Northoff H, Skarke C, Jauch J, Werz OOn the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceEur J Pharmacol.(2009 Mar 15)
45.^Krüger P, Daneshfar R, Eckert GP, Klein J, Volmer DA, Bahr U, Müller WE, Karas M, Schubert-Zsilavecz M, Abdel-Tawab MMetabolism of boswellic acids in vitro and in vivoDrug Metab Dispos.(2008 Jun)
46.^Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, Abdel-Tawab MModulation of Pgp function by boswellic acidsPlanta Med.(2006 May)
47.^Chung MK, Lee H, Mizuno A, Suzuki M, Caterina MJTRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytesJ Biol Chem.(2004 May 14)
48.^Xu H, Ramsey IS, Kotecha SA, Moran MM, Chong JA, Lawson D, Ge P, Lilly J, Silos-Santiago I, Xie Y, DiStefano PS, Curtis R, Clapham DETRPV3 is a calcium-permeable temperature-sensitive cation channelNature.(2002 Jul 11)
49.^Smith GD, Gunthorpe MJ, Kelsell RE, Hayes PD, Reilly P, Facer P, Wright JE, Jerman JC, Walhin JP, Ooi L, Egerton J, Charles KJ, Smart D, Randall AD, Anand P, Davis JBTRPV3 is a temperature-sensitive vanilloid receptor-like proteinNature.(2002 Jul 11)
50.^Bakthira H, Awadh Ali NA, Arnold N, Teichert A, Wessjohann LAnticholinesterase activity of endemic plant extracts from SoqotraAfr J Tradit Complement Altern Med.(2011)
51.^Moussaieff A, Yu J, Zhu H, Gattoni-Celli S, Shohami E, Kindy MSProtective effects of incensole acetate on cerebral ischemic injuryBrain Res.(2012 Mar 14)
52.^Streffer JR, Bitzer M, Schabet M, Dichgans J, Weller MResponse of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15Neurology.(2001 May 8)
53.^Winking M, Sarikaya S, Rahmanian A, Jödicke A, Böker DKBoswellic acids inhibit glioma growth: a new treatment optionJ Neurooncol.(2000)
55.^Leroux E, Ducros ACluster headacheOrphanet J Rare Dis.(2008 Jul 23)
56.^Mahmoudi A, Hosseini-Sharifabad A, Monsef-Esfahani HR, Yazdinejad AR, Khanavi M, Roghani A, Beyer C, Sharifzadeh MEvaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male ratsJ Nat Med.(2011 Jul)
57.^Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss H, Subbaraju GV, Trimurtulu G, Krishnaraju AV, Bagchi M, Bagchi D, Sen CKHuman genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cellsDNA Cell Biol.(2005 Apr)
58.^Cuaz-Pérolin C, Billiet L, Baugé E, Copin C, Scott-Algara D, Genze F, Büchele B, Syrovets T, Simmet T, Rouis MAntiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- miceArterioscler Thromb Vasc Biol.(2008 Feb)
59.^Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri SPComparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical studyInt J Med Sci.(2010 Nov 1)
61.^Abu-Amer Y, Tondravi MMNF-kappaB and bone: the breaking pointNat Med.(1997 Nov)
62.^Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan BTreatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over studyJ Ethnopharmacol.(1991 May-Jun)
65.^Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SPA double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the kneeArthritis Res Ther.(2008)
69.^Martínez-Clemente M, Clària J, Titos EThe 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver diseaseCurr Opin Clin Nutr Metab Care.(2011 Jul)
70.^Gupta I, Parihar A, Malhotra P, Singh GB, Lüdtke R, Safayhi H, Ammon HPEffects of Boswellia serrata gum resin in patients with ulcerative colitisEur J Med Res.(1997 Jan)
71.^Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HP, Safayhi HAcetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activityBr J Pharmacol.(1996 Feb)
72.^Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HPBoswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenaseJ Pharmacol Exp Ther.(1992 Jun)
73.^Safayhi H, Sailer ER, Ammon HPMechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acidMol Pharmacol.(1995 Jun)
74.^Ammon HP, Safayhi H, Mack T, Sabieraj JMechanism of antiinflammatory actions of curcumine and boswellic acidsJ Ethnopharmacol.(1993 Mar)
75.^Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, Schneider G, Jauch J, Poeckel D, Werz OIdentification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acidsBiochem Pharmacol.(2008 Jan 15)
77.^Poeckel D, Werz OBoswellic acids: biological actions and molecular targetsCurr Med Chem.(2006)
80.^Henkel A, Kather N, Mönch B, Northoff H, Jauch J, Werz OBoswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interferenceBiochem Pharmacol.(2012 Jan 1)
82.^Moussaieff A, Shohami E, Kashman Y, Fride E, Schmitz ML, Renner F, Fiebich BL, Munoz E, Ben-Neriah Y, Mechoulam RIncensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activationMol Pharmacol.(2007 Dec)
84.^Siemoneit U, Koeberle A, Rossi A, Dehm F, Verhoff M, Reckel S, Maier TJ, Jauch J, Northoff H, Bernhard F, Doetsch V, Sautebin L, Werz OInhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincenseBr J Pharmacol.(2011 Jan)
85.^Samuelsson B, Morgenstern R, Jakobsson PJMembrane prostaglandin E synthase-1: a novel therapeutic targetPharmacol Rev.(2007 Sep)
86.^Verhoff M, Seitz S, Northoff H, Jauch J, Schaible AM, Werz OA novel C(28)-hydroxylated lupeolic acid suppresses the biosynthesis of eicosanoids through inhibition of cytosolic phospholipase A(2)Biochem Pharmacol.(2012 Sep 1)
87.^Safayhi H, Rall B, Sailer ER, Ammon HPInhibition by boswellic acids of human leukocyte elastaseJ Pharmacol Exp Ther.(1997 Apr)
90.^Khajuria A, Gupta A, Malik F, Singh S, Singh J, Gupta BD, Suri KA, Suden P, Srinivas VK, Ella K, Qazi GNA new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAgVaccine.(2007 Jun 6)
92.^Shehata AM, Quintanilla-Fend L, Bettio S, Singh CB, Ammon HPPrevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE)Phytomedicine.(2011 Sep 15)
94.^Rollinger JM, Kratschmar DV, Schuster D, Pfisterer PH, Gumy C, Aubry EM, Brandstötter S, Stuppner H, Wolber G, Odermatt A11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approachesBioorg Med Chem.(2010 Feb 15)
95.^Borrelli F, Capasso F, Capasso R, Ascione V, Aviello G, Longo R, Izzo AAEffect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipationBr J Pharmacol.(2006 Jun)
96.^Latella G, Sferra R, Vetuschi A, Zanninelli G, D'Angelo A, Catitti V, Caprilli R, Gaudio EPrevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acidEur J Clin Invest.(2008 Jun)
97.^Ke F, Yadav PK, Ju LZHerbal medicine in the treatment of ulcerative colitisSaudi J Gastroenterol.(2012 Jan-Feb)
98.^Hartmann RM, Morgan Martins MI, Tieppo J, Fillmann HS, Marroni NPEffect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acidDig Dis Sci.(2012 Aug)
99.^Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Müller S, Senninger N, Russell J, Jauch J, Bergmann J, Granger DN, Krieglstein CFMechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitisAm J Physiol Gastrointest Liver Physiol.(2006 Jun)
100.^Rhodes JM, Potter BJ, Brown DJ, Jewell DPSerum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitisGastroenterology.(1982 Jun)
101.^Chande N, McDonald JW, Macdonald JKInterventions for treating collagenous colitisCochrane Database Syst Rev.(2008 Apr 16)
102.^Madisch A, Miehlke S, Eichele O, Mrwa J, Bethke B, Kuhlisch E, Bästlein E, Wilhelms G, Morgner A, Wigginghaus B, Stolte MBoswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trialInt J Colorectal Dis.(2007 Dec)
103.^Slonim AE, Grovit M, Bulone LEffect of exclusion diet with nutraceutical therapy in juvenile Crohn's diseaseJ Am Coll Nutr.(2009 Jun)
104.^Holtmeier W, Zeuzem S, Preiss J, Kruis W, Böhm S, Maaser C, Raedler A, Schmidt C, Schnitker J, Schwarz J, Zeitz M, Caspary WRandomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacyInflamm Bowel Dis.(2011 Feb)
105.^Raja AF, Ali F, Khan IA, Shawl AS, Arora DSAcetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogensBMC Res Notes.(2011 Oct 13)
106.^Schillaci D, Arizza V, Dayton T, Camarda L, Di Stefano VIn vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oilsLett Appl Microbiol.(2008 Nov)
108.^Gupta I, Gupta V, Parihar A, Gupta S, Lüdtke R, Safayhi H, Ammon HPEffects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical studyEur J Med Res.(1998 Nov 17)
109.^Clark CE, Arnold E, Lasserson TJ, Wu THerbal interventions for chronic asthma in adults and children: a systematic review and meta-analysisPrim Care Respir J.(2010 Dec)
110.^Houssen ME, Ragab A, Mesbah A, El-Samanoudy AZ, Othman G, Moustafa AF, Badria FANatural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthmaClin Biochem.(2010 Jul)
111.^Lakka A, Mylonis I, Bonanou S, Simos G, Tsakalof AIsolation of hypoxia-inducible factor 1 (HIF-1) inhibitors from frankincense using a molecularly imprinted polymerInvest New Drugs.(2011 Oct)
113.^Belozerov VE, Van Meir EGHypoxia inducible factor-1: a novel target for cancer therapyAnticancer Drugs.(2005 Oct)
115.^Hoernlein RF, Orlikowsky T, Zehrer C, Niethammer D, Sailer ER, Simmet T, Dannecker GE, Ammon HPAcetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase IJ Pharmacol Exp Ther.(1999 Feb)
116.^Castelli S, Coletta A, D'Annessa I, Fiorani P, Tesauro C, Desideri AInteraction between natural compounds and human topoisomerase IBiol Chem.(2012 Nov)
118.^Glaser T, Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M, Weller MBoswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivityBr J Cancer.(1999 May)
121.^Shen Y, Takahashi M, Byun HM, Link A, Sharma N, Balaguer F, Leung HC, Boland CR, Goel ABoswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cellsCancer Biol Ther.(2012 May 1)
122.^Takahashi M, Sung B, Shen Y, Hur K, Link A, Boland CR, Aggarwal BB, Goel ABoswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA familyCarcinogenesis.(2012 Dec)
124.^Liu HP, Gao ZH, Cui SX, Wang Y, Li BY, Lou HX, Qu XJChemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) miceInt J Cancer.(2012 Nov 7)
126.^Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gélinas C, Rabson ABMechanisms of constitutive NF-kappaB activation in human prostate cancer cellsProstate.(2002 Aug 1)
127.^Büchele B, Zugmaier W, Estrada A, Genze F, Syrovets T, Paetz C, Schneider B, Simmet TCharacterization of 3alpha-acetyl-11-keto-alpha-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivoPlanta Med.(2006 Nov)
129.^Kim HR, Kim MS, Kwon DY, Chae SW, Chae HJBosellia serrata-induced apoptosis is related with ER stress and calcium releaseGenes Nutr.(2008 Feb)
130.^Khan S, Chib R, Shah BA, Wani ZA, Dhar N, Mondhe DM, Lattoo S, Jain SK, Taneja SC, Singh JA cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic deathEur J Pharmacol.(2011 Jun 25)
131.^Kaur R, Khan S, Chib R, Kaur T, Sharma PR, Singh J, Shah BA, Taneja SCA comparative study of proapoptotic potential of cyano analogues of boswellic acid and 11-keto-boswellic acidEur J Med Chem.(2011 Apr)
132.^Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa HTargeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solutionAnn N Y Acad Sci.(2006 Dec)
137.^Suhail MM, Wu W, Cao A, Mondalek FG, Fung KM, Shih PT, Fang YT, Woolley C, Young G, Lin HKBoswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cellsBMC Complement Altern Med.(2011 Dec 15)
138.^Mothana RA, Lindequist U, Gruenert R, Bednarski PJStudies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island SoqotraBMC Complement Altern Med.(2009 Mar 25)
139.^Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura MExpression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progressionClin Cancer Res.(2000 Sep)
141.^Ni X, Suhail MM, Yang Q, Cao A, Fung KM, Postier RG, Woolley C, Young G, Zhang J, Lin HKFrankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine modelBMC Complement Altern Med.(2012 Dec 13)
142.^Safayhi H, Sailer ERAnti-inflammatory actions of pentacyclic triterpenesPlanta Med.(1997 Dec)
144.^Calzavara-Pinton P, Zane C, Facchinetti E, Capezzera R, Pedretti ATopical Boswellic acids for treatment of photoaged skinDermatol Ther.(2010 Jan-Feb)
145.^Krishnaraju AV, Sundararaju D, Vamsikrishna U, Suryachandra R, Machiraju G, Sengupta K, Trimurtulu GSafety and toxicological evaluation of Aflapin: a novel Boswellia-derived anti-inflammatory productToxicol Mech Methods.(2010 Nov)
146.^Tripathi YBBHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosisRecent Pat Inflamm Allergy Drug Discov.(2009 Jan)
147.^Su S, Hua Y, Wang Y, Gu W, Zhou W, Duan JA, Jiang H, Chen T, Tang YEvaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carteriiJ Ethnopharmacol.(2012 Jan 31)
148.^Sferra R, Vetuschi A, Catitti V, Ammanniti S, Pompili S, Melideo D, Frieri G, Gaudio E, Latella GBoswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulationEur Rev Med Pharmacol Sci.(2012 Nov)
150.^Lupi S, Marconi S, Paiaro E, Fochesato A, Gregorio PMutagenicity evaluation with Ames test of hydro-alcoholic solution of terpenesJ Prev Med Hyg.(2009 Sep)
151.^Sharma R, Singh S, Singh GD, Khajuria A, Sidiq T, Singh SK, Chashoo G, Pagoch SS, Kaul A, Saxena AK, Johri RK, Taneja SCIn vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodentsPhytomedicine.(2009 Dec)
152.^Acebo E, Ratón JA, Sautúa S, Eizaguirre X, Trébol I, Pérez JLAllergic contact dermatitis from Boswellia serrata extract in a naturopathic creamContact Dermatitis.(2004 Aug)